20 Australia’s outstanding health startups are annually selected for the 12-month program with up to $200,000 in equity-based funding and access to Asia Pacific’s 200+ industry experts, to accelerate the growth towards market.
MedTech Actuator Accelerator is supported by LaunchVic and the REDI Initiative, powered by MTPConnect.
Download the 2023 Accelerator Info Pack here
Through intensive mentorship, industry collaboration, and capital raising support, you can achieve in 12 months what can typically take 3 years or more. The result – is a road-hardened venture primed to compete and built for speed, ready to raise seed funding leading into clinical trials, regulatory approvals, at-scale manufacturing, and market launch.
Program
100% industry-led, based on current, practical experience
Mentors
Unrivalled network of resident and corporate mentors across Asia Pacific
Community
66+ startups in the portfolio and 300+ in the community
Capital
*Up to $200K initial capital injection
Program experience
Learn
Commercialisation fundamentals during the week-long sprint
Network
1:1 mentoring and commercialisation strategy development during the downtime
Expose
Meet our network of investors and partners at the annual Showcase and Demo Day
Pitch
opportunities to refine your pitch and present to different audiences
2023 Program Dates
Applications open – January 2023
First Interviews - March 2023
Due Diligence - March - April 2023
Second interview with Innovation Assessment Board - April 2023
Offers sent - May 2023
4 Intensive sprints – July - October 2023 (5 days each, full-time)
October 2023 - April 2024 - tailored program
MedTech Actuator Showcase (annual gala for the selected startups) – Dec 1, 2023
Demo Day - February 2024
Read about previous alumni
Ajit Ravindran
Through the MedTech Actuator™, we were able to take our innovative idea from concept to a commercial-re... Read more
Anshul Dayal
The MedTech Actuator’s investor networks have been crucial to our success and we’ve recently raised a... Read more
Program Eligibility
At the MedTech Actuator, we’re for innovators. And this means creating opportunities for innovators from all corners of the system, and from multiple backgrounds and contexts. MedTech Actuator encourages applicants from diverse backgrounds to apply. Please read the FAQs and reach out to the team if you have any questions about your eligibility.
*Investment terms for the 2023 Accelerator
The MedTech Actuator takes 5% equity for participation in the program.
Access to capital is required to participate in the program. Companies must have access to a minimum of $50,000 to ensure that reports and documents critical to future investment rounds can be completed in the first 6 months of the program. This cash flow can be either self-funded through the ‘unfunded track’, or from The MedTech Actuator fund as part of ‘the funded track’.
Through an exclusive venture partnership, startups may be eligible for pre-seed investment. The minimum investment is $50,000 up to a maximum of $200,000. For every $10,000 that our fund invests, we will take 1% equity.
Expression of Interest (startups)
If you are an early-stage team, consider joining our pre-accelerator Origin – the selected teams will be fast-tracked to the Accelerator program
Read More
Announcing MedTech Actuator Showcase 2022 Award Winners
At the recent MedTech Actuator Showcase, we joined ecosystem leaders to celebrate Asia Pacific’s next wave of early-stage MedTech, HealthTech and BioTech entrepreneurs – with four taking home prestigious awards.
MedTech Actuator Showcase 2022 Lineup Announced
The annual MedTech Actuator Showcase brings together leaders and representatives from both the Australian and global health innovation ecosystems. The night will connect and celebrate the achievements, impact and progress of MedTech Actuator entrepreneurs and founders.
From fighting cancer to founding ChezLeon: Cheryl Pollock’s story
October is Breast Cancer Awareness month and MedTech Actuator would like to acknowledge the impacts of breast cancer and the importance of creating awareness about it.
